Insights

Strategic Alliance Endo Pharmaceuticals' merger with Mallinckrodt Pharmaceuticals has led to the creation of specialized entities like Keenova Therapeutics and Par Health, offering targeted therapeutic and generic injectable solutions. This strategic focus presents opportunities to collaborate on innovative drug development and supply chain efficiencies within their niche markets.

Innovative Technologies Endo's deployment of advanced tech such as Spatial Computing Injection Simulator and sophisticated digital tools indicates a commitment to cutting-edge R&D and patient engagement. These innovations open avenues for sales of related medical devices, software solutions, or digital health integrations to enhance clinical and patient outcomes.

Financial Rebuilding Despite emerging from Chapter 11 bankruptcy, Endo secured significant financing of $900 million, demonstrating a strong financial position to invest in new product launches and market expansion efforts. Sales opportunities may exist in supporting their growth initiatives through logistics, marketing, or new pharmaceutical formulations.

Market Expansion Recent product launches like Tiopronin delayed-release tablets and branded TV advertising campaigns for treatments such as Xiaflex suggest an active push into new therapeutic areas and increased brand visibility. This provides potential for sales of medical supplies, marketing services, and distribution channels to support their expanding portfolio.

Market Trends Endo's focus on branded therapies, generics, and sterile injectables positions them well within high-demand sectors amid industry shifts toward affordability and innovation. Business development opportunities lie in providing tailored solutions in manufacturing, regulatory consulting, or supply chain optimization to meet evolving market needs.

Similar companies to Endo Pharmaceuticals

Endo Pharmaceuticals Tech Stack

Endo Pharmaceuticals uses 8 technology products and services including Umbraco, Snowflake, DocuSign, and more. Explore Endo Pharmaceuticals's tech stack below.

Umbraco
Content Management System
Snowflake
Data Management Platforms
DocuSign
Miscellaneous
Microsoft Windows
Operating Systems
UNIX
Operating Systems
Akamai mPulse
Real User Monitoring
Minitab
Visualisation Software
Adobe Creative Suite
Visualisation Software

Media & News

Endo Pharmaceuticals's Email Address Formats

Endo Pharmaceuticals uses at least 1 format(s):

Endo Pharmaceuticals Email Formats	Example	Percentage
Last.First@endo.com	Doe.John@endo.com	72%
First.Last@endo.com	John.Doe@endo.com	22%
First@endo.com	John@endo.com	4%
LastFirst@endo.com	DoeJohn@endo.com	2%

Frequently Asked Questions

Where is Endo Pharmaceuticals's headquarters located?

Endo Pharmaceuticals's main headquarters is located at Malvern, Arkansas United States. The company has employees across 6 continents, including North AmericaAsiaEurope.

What is Endo Pharmaceuticals's phone number?

You can contact Endo Pharmaceuticals's main corporate office by phone at

+1-610-558-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Endo Pharmaceuticals's stock symbol?

Endo Pharmaceuticals is a publicly traded company; the company's stock symbol is ECYT.

What is Endo Pharmaceuticals's official website and social media links?

Endo Pharmaceuticals's official website is endo.com and has social profiles on LinkedIn.

What is Endo Pharmaceuticals's SIC code NAICS code?

Endo Pharmaceuticals's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Endo Pharmaceuticals have currently?

As of February 2026, Endo Pharmaceuticals has approximately 1.6K employees across 6 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer: A. B.Ceo: S. M.Ceo: D. H.. Explore Endo Pharmaceuticals's employee directory with LeadIQ.

What industry does Endo Pharmaceuticals belong to?

Endo Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Endo Pharmaceuticals use?

Endo Pharmaceuticals's tech stack includes UmbracoSnowflakeDocuSignMicrosoft WindowsUNIXAkamai mPulseMinitabAdobe Creative Suite.

What is Endo Pharmaceuticals's email format?

Endo Pharmaceuticals's email format typically follows the pattern of Last.First@endo.com. Find more Endo Pharmaceuticals email formats with LeadIQ.

When was Endo Pharmaceuticals founded?

Endo Pharmaceuticals was founded in 1997.

Endo Pharmaceuticals

Q: What is Endo Pharmaceuticals's official website and social media links?

Endo Pharmaceuticals's official website is endo.com. Endo Pharmaceuticals has social profiles on LinkedIn.

Q: How many employees does Endo Pharmaceuticals have currently?

Endo Pharmaceuticals has approximately 1.6K employees.

Q: What technology does Endo Pharmaceuticals use?

Endo Pharmaceuticals's tech stack includes Amazon Web Services, Microsoft Word, Google Charts, Google Cloud Platform, Apple iCloud Mail.

Pharmaceutical ManufacturingArkansas, United States1001-5000 Employees

Endo combined with Mallinckrodt Pharmaceuticals in 2025 to better serve customers and improve outcomes for the patients we support.

From this union, we established two focused, standalone companies:

– Keenova Therapeutics, a branded therapeutics business
– Par Health, a generics and sterile injectables business

To learn more, follow Keenova and Par Health on LinkedIn and visit keenova.com and parhealth.com.